1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Nobel Biocare

Anonymous board for Nobel Biocare


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    44
    Views:
    5,628
  2. anonymous
    Replies:
    20
    Views:
    3,556
  3. Anonymous
    Replies:
    103
    Views:
    20,702
  4. anonymous
    Replies:
    2
    Views:
    443
  5. anonymous
    Replies:
    1
    Views:
    312
  6. Jenna
    Replies:
    0
    Views:
    325
  7. anonymous
    Replies:
    0
    Views:
    145
  8. anonymous
    Replies:
    18
    Views:
    9,612
  9. anonymous
    Replies:
    2
    Views:
    1,461
  10. anonymous
    Replies:
    7
    Views:
    1,100
  11. Anonymous
    Replies:
    21
    Views:
    7,688
  12. Anonymous
    Replies:
    21
    Views:
    8,222
  13. Anonymous
    Replies:
    20
    Views:
    7,956
  14. Jenna Wieslaw
    Replies:
    2
    Views:
    632
  15. Anonymous
    Replies:
    126
    Views:
    24,619
  16. anonymous
    Replies:
    2
    Views:
    654
  17. anonymous
    Replies:
    34
    Views:
    8,687
  18. anonymous
    Replies:
    4
    Views:
    826
  19. anonymous
    Replies:
    2
    Views:
    664
  20. anonymous
    Replies:
    0
    Views:
    633

Thread Display Options

Loading...